Standing united in the fight against the unknown

The spread of the coronavirus to more economies, the imposition of social distancing and draconian policy measures across most of the Western world, plus ongoing financial market turmoil despite heavy central bank intervention, have led us to make further significant across-the-board cuts to our 2020 GDP and growth forecasts. 

EPTDA recognizes the critical importance of reliable and up-to-date information on the market outlook and economic forecasts in these fast-changing, challenging and uncertain times. My team and our partners – at Oxford Economics and ITR Economics – are committed to providing the support and information you need to help navigate this unknown territory.

Please don't hesitate to get in touch with us directly in case of any questions at [email protected]. We would love to stay close and understand how we can provide support, guidance and information. What kind of data and research you would like to receive in addition to our regular sources?

If you have a success story to share, from your company or peers, do share it with us.

The many restrictions on movement and ability to work that have occurred over the past several weeks in Europe, the US and elsewhere, are having a significant effect on all of us in our daily lives, and will have severe short-term adverse consequences for the global economy. It is becoming increasingly clear that the downside of this global pandemic is here to stay for a while.

Please stay safe, stay vigilant, stay informed and help each other by sharing knowledge and best practices.

View our latest Market Insights expert opinions:

Oxford Economics: Quarterly Industry Outlook Q1-2020

Coronavirus inflicts a short, sharp recession on global economy

ITR Economics: Quarterly Review & Forecast Q1-2020

Sustainable Rise in Annual Production Not Expected Until Late This Year in Europe.

EU Monitoring: The Virus & The Supply Chain

https://www.eptda.org/membership/membership-advantages/market-insights/eu-monitoring/ 

How businesses are fighting COVID-19: Forbes Magazine

Armani: Billionaire Giorgio Armani’s luxury fashion brand converted all production at its Italian factories to manufacture single-use medical overalls.

BioNTech: German biotech firm backed by billionaire twins Thomas and Andreas Struengmann is working to develop a Corona virus vaccine in partnership with Pfizer and Fosun Pharma, chaired by billionaire Guo Guangchang.

Carbon: California-based 3D printing unicorn backed by Russian tech investor Yuri Milner will soon be distributing testing swabs and face shields to hospitals in the Bay Area.

Carbyne: New York startup’s emergency response tool, backed by Peter Thiel’s VC fundusers, is being used by 911 responders in New Orleans to track patients by video screening callers.

CureVac: German firm, funded by billionaire Dietmar Hopp and the Bill and Melinda Gates Foundation, received $87 million from the European Commission to scale up development of its Corona virus vaccine.

DiaSorin: Italian biotech company owned by billionaire Gustavo Denegri obtained emergency authorization from the FDA for its new 60-minute testing kit for COVID-19.

Dyson: British billionaire James Dyson announced his vacuum cleaner and hand dryer firm would start designing and making 10,000 ventilators, with more to come.

Ford: Auto giant is working with 3M and GE’s healthcare unit to make respirators, ventilators and face shields at its manufacturing sites; Ford and GE Healthcare announced on March 30 that the companies would produce 50,000 ventilators by July 8 with plans to increase production to 30,000 a month.

Gojo Industries: The Ohio-based maker of Purell, owned by a billionaire family, is prioritizing delivery of its ubiquitous hand sanitizers to health workers and first responders on the frontlines.

Johnson & Johnson: The company’s pharma unit, Janssen, will start manufacturing its vaccine — developed with the Department of Health and Human Services — this month, with human trials set to begin by September and a public rollout hoped for early 2021. The company and the federal government are investing more than $1 billion in the vaccine effort.

Medline: Northfield, Illinois family-owned manufacturer is ramping up production to supply medical masks, biohazard bags, surgical clothing and disinfectants to hospitals across the United States.

Medtronic: Minnesota-based medical device maker publicly shared the design specifications for its basic ventilator model, with the goal of helping other companies quickly manufacture ventilators.